RT Journal Article
SR Electronic
T1 First report of a very rare complication in a case of nonsmall cell lung carcinoma
JF Breathe
JO Breathe
FD European Respiratory Society
SP 210107
DO 10.1183/20734735.0107-2021
VO 17
IS 4
A1 Inês Moreira
A1 Ana Sofia Vilariça
A1 Paula Alves
YR 2021
UL http://breathe.ersjournals.com/content/17/4/210107.abstract
AB While immune checkpoint inhibitors like pembrolizumab are promising agents for nonsmall cell lung carcinoma treatment, increased use is leading to increased immune-related adverse events, including endocrinopathies such as adrenal insufficiency. https://bit.ly/3iMfhUk